Comparison of King Vision Video Laryngoscope to McGrath MAC Video Laryngoscope for Nasal Intubation

NCT ID: NCT03129399

Last Updated: 2017-05-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-20

Study Completion Date

2018-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was designed to determine the comparison between the King Vision video laryngoscope and McGrath MAC video laryngoscope for nasotracheal intubation.Patients were divided into 2 groups of 40 patients each.Patients of King Vision group \[n=40\]and Macintosh group \[n=40\]were intubated using respective devices.This study is the first to search the use of King Vision video laryngoscope for nasotracheal intubation in difficult airway.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nasal Intubation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

King Vision video laryngoscope

Group Type EXPERIMENTAL

King Vision video laryngoscope

Intervention Type DEVICE

nasal intubation using King Vision video laryngoscope Device after general anesthesia induction

McGrath MAC video laryngoscope

Group Type ACTIVE_COMPARATOR

McGrath MAC video laryngoscope

Intervention Type DEVICE

nasal intubation with McGrath MAC video laryngoscope Device after general anesthesia induction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

King Vision video laryngoscope

nasal intubation using King Vision video laryngoscope Device after general anesthesia induction

Intervention Type DEVICE

McGrath MAC video laryngoscope

nasal intubation with McGrath MAC video laryngoscope Device after general anesthesia induction

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA physical status 1-2
* Scheduled for general anesthesia with nasotracheal intubation
* Cormach-Lehane score 3-4

Exclusion Criteria

* contraindications to nasal intubation
* Patients with a history of anti-hypertensive drugs
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sun Yu

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai Ninth People's Hospital,Affililated to Shanghai Jiaotong University School of Medicine

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yu Sun, MD,PhD

Role: CONTACT

0086-136-1189-5542

Haozhen Zhu, MM

Role: CONTACT

0086-189-1889-0657

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yu Sun, MD,PhD

Role: primary

0086 13611895542

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

suny

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.